General Info

From its inception, the people of Gilead Sciences across North America, Europe and Australia have shared a vision of advancing therapeutics for life-threatening diseases worldwide. As one of the leading biopharmaceutical companies, it has been fulfilling that vision for more than a decade discovering, developing and commercializing small molecule therapeutics to advance the care of patients suffering from life-threatening infectious diseases. In addition to its marketed products, Gilead has a clinical, preclinical and research pipeline focused on developing anti-infectives. The company has approximately 1,800 employees, has operations in North America, Europe and Australia. In North America, corporate headquarters are based in Foster City, Calif., with additional operations in San Dimas, Calif.; Durham, N.C., and Toronto. European operations are based in Uxbridge, United Kingdom and Dublin, Ireland. Additionally, sales and marketing organizations are located in the following cities: Athens, Greece; Cambridge, United Kingdom; Lisbon, Portugal; Madrid, Spain; Melbourne, Australia; Milan, Italy; Munich, Germany and Paris.